Loading...
•
Mar 31, 2021
Teladoc Q1 2021 Earnings Report
Teladoc Health's first quarter results were reported, showing significant revenue growth and increased consumer engagement.
Key Takeaways
Teladoc Health reported a strong first quarter with revenue increasing by 151% year-over-year to $453.7 million and total visits increasing by 56% to 3.2 million. The company is making progress on its integration efforts, including the launch of Medical Group referrals into chronic care management programs and a new whole-person care contract. The company raised its full-year guidance.
Revenue grew 151% year-over-year to $453.7 million.
Total visits increased 56% to 3.2 million.
Consumers enrolled in multiple chronic care programs tripled year-over-year.
Substantial progress was made on integration efforts.
Revenue by Segment
Revenue by Geographic Location
Forward Guidance
Teladoc Health provides guidance based on current market conditions and expectations. For the second-quarter 2021, total revenue is expected to be in the range of $495 million to $505 million and total visits to be between 3.2 million and 3.4 million. For the full-year 2021, total revenue is expected to be in the range of $1,970 million to $2,020 million and total visits to be between 12.5 million and 13.5 million.
Positive Outlook
- Total revenue to be in the range of $495 million to $505 million for Q2 2021.
- Adjusted EBITDA to be in the range of $61 million to $64 million for Q2 2021.
- Total U.S. paid membership to be in the range of 52 million to 53 million members for Q2 2021.
- Total visits to be between 3.2 million and 3.4 million for Q2 2021.
- Total revenue to be in the range of $1,970 million to $2,020 million for full year 2021.
Challenges Ahead
- EBITDA to be in the range of $(38) million to $(35) million for Q2 2021.
- EBITDA to be in the range of $(120) million to $(100) million for full year 2021.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...